Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

23andMe: a new two-sided data-banking market model.

BMC medical ethics - 31 Mar 2016

Stoeklé Henri-Corto, Mamzer-Bruneel Marie-France, Vogt Guillaume, Hervé Christian

Abstract excerpt

BACKGROUND: Since 2006, the genetic testing company 23andMe has collected biological samples, self-reported information, and consent documents for biobanking and research from more than 1,000,000 individuals (90% participating in research), through a direct-to-consumer (DTC) online genetic-testing service providing a genetic ancestry report and a genetic health report. However, on November 22, 2013, the Food and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Specimen Banks
Share to Biomedical Research
Share to Bloom Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Informed Consent

Share to Reproducibility of Results

Share to United States

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 27059184
DOI: 10.1186/s12910-016-0101-9
PMCID: PMC4826522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

23andMe: a new two-sided data-banking market model.PMID 27059184Read ↗

DNA Data Marketplace: An Analysis of the Ethical Concerns Regarding the Participation of the IndividualsSemantic proximity Read ↗

Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?Semantic proximity Read ↗

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic TestingSemantic proximity Read ↗

The next controversy in genetic testing: clinical data as trade secrets?Semantic proximity Read ↗

The challenges of the expanded availability of genomic information: an agenda-setting paperSemantic proximity Read ↗

Ethical and human subject burdens of trials conducted to evaluate biosimilarsSemantic proximity Read ↗

Perceptions of Biobanking in Lebanon: Implications for Policy, Ethics, and Regional Research IntegrationSemantic proximity Read ↗

The Impact of Commercialisation and Genetic Data Sharing Arrangements on Public Trust and the Intention to Participate in Biobank ResearchSemantic proximity Read ↗

Building a data sharing model for global genomic researchSemantic proximity Read ↗

COVID-19 Trade Secrets and Information Access: An OverviewSemantic proximity Read ↗

Should commercial diagnostic testing be stimulated or discouraged? Analyzing willingness-to-pay and market externalities using three case studies from the NetherlandsSemantic proximity Read ↗

Partnership in U.K. Biobank: A Third Way for Genomic Property?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.